Modulators of cystic fibrosis transmembrane conductance regulator

Details for Australian Patent Application No. 2010226393 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Yang, Xiaoqing; Hadida Ruah, Sara S.; Grootenhuis, Peter D.J.; Van Goor, Fredrick F.; Botfield, Martyn C.; Zlokarnik, Gregor

Agent Cullens

Pub. Number AU-A-2010226393

PCT Pub. Number WO2010/108155

Priority 61/162,130 20.03.09 US

Filing date 19 March 2010

Wipo publication date 23 September 2010

International Classifications

C07D 215/233 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/108155 Priority application(s): WO2010/108155

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010226395-Methods and systems for searching, selecting, and displaying content

2010226392-Selective and potent peptide inhibitors of Kv1.3